172 related articles for article (PubMed ID: 15196820)
1. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by NMSO3 in tissue culture assays.
Wyde PR; Moylett EH; Chetty SN; Jewell A; Bowlin TL; Piedra PA
Antiviral Res; 2004 Jul; 63(1):51-9. PubMed ID: 15196820
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro.
Wyde PR; Chetty SN; Jewell AM; Boivin G; Piedra PA
Antiviral Res; 2003 Sep; 60(1):51-9. PubMed ID: 14516921
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo.
Miller AL; Bowlin TL; Lukacs NW
J Infect Dis; 2004 Apr; 189(8):1419-30. PubMed ID: 15073679
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of NMSO3-resistant mutants of respiratory syncytial virus.
Kimura K; Ishioka K; Hashimoto K; Mori S; Suzutani T; Bowlin TL; Shigeta S
Antiviral Res; 2004 Mar; 61(3):165-71. PubMed ID: 15168797
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo.
Kimura K; Mori S; Tomita K; Ohno K; Takahashi K; Shigeta S; Terada M
Antiviral Res; 2000 Jul; 47(1):41-51. PubMed ID: 10930645
[TBL] [Abstract][Full Text] [Related]
6. Serological cross-reactivity of members of the Metapneumovirus genus.
Alvarez R; Jones LP; Seal BS; Kapczynski DR; Tripp RA
Virus Res; 2004 Sep; 105(1):67-73. PubMed ID: 15325082
[TBL] [Abstract][Full Text] [Related]
7. Development of a cotton rat-human metapneumovirus (hMPV) model for identifying and evaluating potential hMPV antivirals and vaccines.
Wyde PR; Chetty SN; Jewell AM; Schoonover SL; Piedra PA
Antiviral Res; 2005 Apr; 66(1):57-66. PubMed ID: 15781133
[TBL] [Abstract][Full Text] [Related]
8. Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity.
Buchholz UJ; Biacchesi S; Pham QN; Tran KC; Yang L; Luongo CL; Skiadopoulos MH; Murphy BR; Collins PL
J Virol; 2005 Jun; 79(11):6588-97. PubMed ID: 15890897
[TBL] [Abstract][Full Text] [Related]
9. Clinical course of hospitalised children infected with human metapneumovirus and respiratory syncytial virus.
Morrow BM; Hatherill M; Smuts HE; Yeats J; Pitcher R; Argent AC
J Paediatr Child Health; 2006 Apr; 42(4):174-8. PubMed ID: 16630317
[TBL] [Abstract][Full Text] [Related]
10. Ge-Gen-Tang has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines.
Chang JS; Wang KC; Shieh DE; Hsu FF; Chiang LC
J Ethnopharmacol; 2012 Jan; 139(1):305-10. PubMed ID: 22120014
[TBL] [Abstract][Full Text] [Related]
11. Antiviral Activity of Favipiravir (T-705) against a Broad Range of Paramyxoviruses In Vitro and against Human Metapneumovirus in Hamsters.
Jochmans D; van Nieuwkoop S; Smits SL; Neyts J; Fouchier RA; van den Hoogen BG
Antimicrob Agents Chemother; 2016 Aug; 60(8):4620-9. PubMed ID: 27185803
[TBL] [Abstract][Full Text] [Related]
12. Liu-He-Tang inhibited plaque formation by human respiratory syncytial virus infection in cell lines of the human respiratory tract.
Chang JS; Wang KC; Shieh DE; Chiang LC
J Ethnopharmacol; 2011 Oct; 137(3):1149-55. PubMed ID: 21810459
[TBL] [Abstract][Full Text] [Related]
13. Effect of NMSO3 treatment in a murine model of human metapneumovirus infection.
Spetch L; Bowlin TL; Casola A
J Gen Virol; 2008 Nov; 89(Pt 11):2709-2712. PubMed ID: 18931066
[TBL] [Abstract][Full Text] [Related]
14. Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo.
Pham QN; Biacchesi S; Skiadopoulos MH; Murphy BR; Collins PL; Buchholz UJ
J Virol; 2005 Dec; 79(24):15114-22. PubMed ID: 16306583
[TBL] [Abstract][Full Text] [Related]
15. Most human metapneumovirus and human respiratory syncytial virus in infant nasal secretions is cell free.
Semple MG; Booth JA; Ebrahimi B
J Clin Virol; 2007 Nov; 40(3):241-4. PubMed ID: 17920332
[TBL] [Abstract][Full Text] [Related]
16. Comparison of human metapneumovirus, respiratory syncytial virus and influenza A virus lower respiratory tract infections in hospitalized young children.
Wolf DG; Greenberg D; Kalkstein D; Shemer-Avni Y; Givon-Lavi N; Saleh N; Goldberg MD; Dagan R
Pediatr Infect Dis J; 2006 Apr; 25(4):320-4. PubMed ID: 16567983
[TBL] [Abstract][Full Text] [Related]
17. Virucidal activities of medium- and long-chain fatty alcohols and lipids against respiratory syncytial virus and parainfluenza virus type 2: comparison at different pH levels.
Hilmarsson H; Traustason BS; Kristmundsdóttir T; Thormar H
Arch Virol; 2007; 152(12):2225-36. PubMed ID: 17891329
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate.
Biacchesi S; Skiadopoulos MH; Yang L; Lamirande EW; Tran KC; Murphy BR; Collins PL; Buchholz UJ
J Virol; 2004 Dec; 78(23):12877-87. PubMed ID: 15542640
[TBL] [Abstract][Full Text] [Related]
19. Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cells.
Le Nouën C; Hillyer P; Munir S; Winter CC; McCarty T; Bukreyev A; Collins PL; Rabin RL; Buchholz UJ
PLoS One; 2010 Nov; 5(11):e15017. PubMed ID: 21124776
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human metapneumovirus replication by small interfering RNA.
Deffrasnes C; Cavanagh MH; Goyette N; Cui K; Ge Q; Seth S; Templin MV; Quay SC; Johnson PH; Boivin G
Antivir Ther; 2008; 13(6):821-32. PubMed ID: 18839783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
